Aug 2026· International Journal of Molecular Sciences· Vol 27, pp. 7439· 0 citations· 25 references
Medicine
TL;DR
Clear pharmacological evidence is provided that the neuroprotective effect of regular treadmill exercise against chronic PD strictly depends on the Nrf2-ARE pathway, indicating that Nrf2 is a key mechanistic node linking exercise and neuroprotection.
Abstract
Currently, effective disease-modifying treatments for Parkinson’s disease (PD) remain lacking. Although exercise has been confirmed to exert neuroprotective effects against PD, its specific molecular mechanisms remain unclear. In particular, the causal role of the Nuclear Factor E2-related Factor 2 (Nrf2)–antioxidant response element (ARE) signaling axis in this process has not been clearly elucidated. This study aimed to provide direct causal evidence that regular treadmill exercise protects the substantia nigra pars compacta (SNc)–striatal dopaminergic system by activating the Nrf2-ARE pathway. The results showed that exercise significantly improved motor function deficits in PD mice, preserved the number of TH-positive neurons, and restored striatal dopamine homeostasis. Mechanistically, exercise activated the Nrf2-ARE pathway, thereby inhibiting the accumulation of mitochondrial ROS (mtROS) and the activation of pro-inflammatory amoeboid microglia in the substantia nigra. Crucially, the improvements in behavioral, neuropathological, and neurochemical indicators induced by exercise were completely reversed, returning to levels comparable to those in the sedentary model group. In conclusion, this study provides clear pharmacological evidence that the neuroprotective effect of regular treadmill exercise against chronic PD strictly depends on the Nrf2-ARE pathway. These findings indicate that Nrf2 is a key mechanistic node linking exercise and neuroprotection, providing reliable preclinical evidence for Nrf2-targeted disease-modifying strategies in PD rehabilitation.
Acteoside (ACT), a compound extracted from Cistanche tubulosa, was found to exert neuroprotective effects in dopaminergic neurons and improved the synucleinopathy in a mouse PD model, providing evidence that ACT could be a potential therapeutic agent for PD.
Ya-Tan Li, Yu-Jie Zeng, Q. Luo et al.· Biomedicine & pharmacotherap...· 0 citations
The natural flavonoid Astragalin concurrently addresses three core pathological processes in PD, namely dopaminergic neuron degeneration, α-synucleinopathy, and neuroinflammation, through coordinated modulation of interconnected molecular pathways.
Jun Wang, Jie-Yu He, Qin Huang et al.· Free Radical Biology & Medic...· 0 citations
Results demonstrate that SLE exerts neuroprotective effects through coordinated regulation of the AMPK -Nrf2 signaling axis and mitochondrial quality control pathways, and suggest that SLE influences mitochondrial homeostasis under oxidative stress conditions.
Chiharu Ueda, Tamaki Tokumatsu, Fuka Sogame et al.· Frontiers in Nutrition· 0 citations
JP1 acts as a promising coordinator of antioxidant and autophagic processes by targeting the Keap1-Nrf2-ARE pathway, thus highlighting its therapeutic potential for ALS.
Yu Zhang, Yaxi Liu, Shiyu Shi et al.· BMC Medicine· 0 citations
The significance of natural terpenoids, with their unique regulatory role in oxidative stress, as a promising candidate library for Alzheimer's drug development is underscored due to their diverse structures, clear mechanisms, and high safety profile.
It is indicated that ginsenoside Rh1 exerts neuroprotective effects against AD in vivo and in vitro, at least partly through SIRT1-related signaling, which subsequently attenuates oxidative stress and ameliorates mitochondrial dysfunction.
Shi-Lu Li, Tao Lin, Wan-Chen Zou et al.· Phytotherapy Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.